Conversely, BCL2 expression was not modulated by the compound in T cells isolated from patients with CLL, thereby reinforcing the notion that EC-7072 is highly efficient at inducing leukemia cell apoptosis compared to other immune cell subsets in patients with CLL (Supplementary Figures 7C,D). This evidence concerns the gene BCL2 and leukemia.